Do You Need Two Low Testosterone Tests for TRT?
Last updated:
By TRT Provider Guide · Last verified: October 2026 · Editorial research. This page has not been reviewed by a clinician.
Yes, in most routine evaluations for male hypogonadism, one low testosterone result is not enough. Do you need two low testosterone tests for TRT? The American Urological Association (AUA) calls for two total testosterone tests on separate occasions, both early in the morning, plus symptoms or signs. The Endocrine Society also calls for repeat early-morning testing, and current FDA testosterone labels tell clinicians to confirm low testosterone on at least two separate morning measurements before treatment.
But the second test is where most people get stuck. It comes back higher, or “borderline,” and nobody explains what happens next. Below, we walk through every common result, why the repeat test matters, what some insurers require, and what current online programs publicly say about confirmatory testing.
Quick answer by situation
| Your situation | What it means |
|---|---|
| One low result | Not enough on its own for the usual guideline-based diagnosis. A second early-morning test is the standard next step. |
| Two low morning results on different days | Key evidence for a diagnosis, but not automatic approval for TRT. Symptoms or signs, cause, safety factors and fertility plans still matter. |
| One low, one normal | The results disagree. The AUA says clinician judgment can be used to decide whether a third test should be considered. |
| Symptoms, but normal results | Symptoms alone do not prove testosterone deficiency. Another cause may need to be evaluated. |
TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.
This page is educational information, not medical advice. It cannot tell you whether you have low testosterone or whether TRT is right for you. If you have a sudden severe headache, vision loss, chest pain, trouble breathing, or another emergency symptom, seek urgent or emergency care.
Who says you need two low testosterone tests for TRT?
The AUA, the Endocrine Society and current FDA testosterone labeling all use repeat morning testing to confirm low testosterone before treatment. The basic idea is consistent: do not make the diagnosis from one isolated number. Details differ, especially around fasting and insurance documentation.
The rule is not one clinic’s preference. We put the wording from the major sources side by side so you can see where they agree and where they do not.
The Two-Test Rule, source by source
| Source | How many tests | When | Fasting? | What else matters |
|---|---|---|---|---|
| American Urological Association guideline | Two, on separate occasions | Early morning | The AUA says clinicians should not insist on fasting because evidence for the food effect is weak | Low testosterone plus symptoms and/or signs. Total testosterone below 300 ng/dL is a reasonable cutoff in support of diagnosis, not a diagnosis by itself |
| Endocrine Society guideline and July 16, 2026 statement | Repeat testing; 2026 statement says “at least two” | Early morning | Yes | Symptoms/signs plus consistently low, accurately measured testosterone; accurate standardized assays are emphasized |
| Current FDA testosterone labeling | At least two separate days | Morning | Not stated as a universal requirement in the labels checked | Results below the normal range before initiating the labeled testosterone product |
| Medicare: Palmetto GBA LCD L39086 | At least two | Before 10 a.m., on different days | Yes | Identical laboratories plus LH or FSH in the diagnostic pathway described by the LCD |
| Medicare: Noridian LCD L36538 | At least two | Two different mornings | Not stated | Symptoms documented plus LH or FSH; the LCD also allows two morning free or bioavailable testosterone measurements in the described pathway |
Sources: AUA testosterone deficiency guideline and full text PDF; Endocrine Society guideline; Endocrine Society 2026 statement; FDA Testim prescribing information; Medicare L39086; Medicare L36538. Checked October 2, 2026.
A few terms you will see on this page:
- Total testosterone is the total amount measured in your blood, including testosterone bound to proteins and the smaller unbound fraction.
- Free testosterone is the unbound fraction. The Endocrine Society recommends considering it when total testosterone is near the lower limit of normal or when a condition changes sex hormone-binding globulin (SHBG).
- FDA-approved testosterone means FDA reviewed that specific finished drug product for its labeled use. Compounded testosterone is not FDA-approved. Medical diagnostic guidance still applies when a clinician is deciding whether testosterone treatment is appropriate.
- Hypogonadism is testosterone deficiency caused by dysfunction of the testes, pituitary or hypothalamic system, depending on the type.
What this means for you: if a clinician asks for another morning test after one low result, that is consistent with the main U.S. diagnostic guidance and current testosterone labeling.
The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.
Have one low result and not sure what comes next? Map your next step, from repeat testing to the right kind of clinician, with TRT Provider Guide's free Find My TRT Path tool. It is educational and does not diagnose low testosterone or determine whether you qualify for a prescription.
Why isn't one low testosterone test enough?
Testosterone can change with time of day, acute illness, normal day-to-day variation and the laboratory method used. One low reading may not represent a repeatable pattern. The AUA notes that about 30% of men with an initial testosterone result in the hypogonadal range have a normal result when the test is repeated.
Think of the first low result as a clue, not a verdict. The second test asks whether the pattern holds up under another properly timed measurement.
Here is what can move the number:
- Time of day. Testosterone is usually highest in the morning in men with conventional sleep schedules. Our review of 19 published studies found meaningful morning-to-later-day differences. See our time-of-day dataset.
- Food. The Endocrine Society recommends fasting morning testing. The AUA agrees on early-morning testing but does not insist on fasting because it considers the evidence for a food effect too weak to make fasting universal.
- Being sick. The AUA says acute illness can temporarily lower testosterone and should be considered when interpreting a result.
- The lab method. The Endocrine Society's 2026 statement warns that non-standardized assays can classify the same sample differently. It urges use of testosterone assays standardized through the CDC Hormone Standardization (HoSt) program when possible.
TRT can also affect sperm production and requires clinical monitoring. Confirming the diagnosis before treatment helps avoid making a long-term treatment decision from one potentially misleading measurement.
What this means for you: a higher second result is not “failing.” It is useful information about whether the first low result is reproducible.
Do both testosterone tests need to be early morning and fasting?
Early-morning testing is the common standard. Fasting is where the major sources differ: the Endocrine Society recommends morning fasting testing, while the AUA says clinicians should not insist on fasting because the evidence supporting that requirement is weak. If a payer or ordering clinician gives specific preparation instructions, those instructions control your test.
Morning: strong agreement
The AUA calls for both total testosterone measurements to be conducted in an early-morning fashion. The Endocrine Society's 2026 statement likewise describes at least two early-morning tests. Current FDA testosterone labels checked for this article also use morning measurements before treatment.
Some payer policies are even more specific. Palmetto GBA's Medicare LCD requires fasting levels drawn before 10 a.m. BCBS Mississippi's current policy requires two morning samples collected between 8 and 10 a.m.
Fasting: the honest split
| Source | Fasting? |
|---|---|
| Endocrine Society | Yes, morning and fasting |
| Medicare Palmetto GBA (L39086) | Yes |
| AUA | Does not require clinicians to insist on fasting |
If you are being tested for a diagnosis or insurance authorization, ask the ordering clinician or lab what preparation applies to your order. Do not assume every insurer follows the same fasting rule.
Work nights? The AUA's discussion of morning testing is based on conventional sleep patterns. If your sleep schedule is different, tell your clinician and ask how they want the draw timed rather than guessing from a fixed clock time.
How far apart should your two testosterone tests be?
The AUA does not set one exact number of days between the two measurements; it says there is no definitive evidence for an optimal interval. Coverage policies can add their own timing rules, so the right interval may depend on the insurer or program involved.
Here are examples from current or still-public coverage criteria:
| Policy | Gap between tests |
|---|---|
| AUA guideline | Separate occasions; no evidence-based optimal interval specified |
| Washington Medicaid | At least 1 week and no more than 3 months apart |
| Aetna implantable testosterone policy | Different days |
| Medicare Palmetto GBA | Two different days |
| Medicare Noridian | Two different mornings |
| UnitedHealthcare commercial medical-benefit policy | Separate times |
What this means for you: do not chase an arbitrary “perfect” number of days. Follow the timing on your clinician's order and, if insurance is paying, the applicable coverage policy.
How do you make your second testosterone test useful?
Use the preparation and timing your clinician or laboratory gives you, and try to keep avoidable sources of variation consistent. Do not stop prescribed medicines, change your sleep on purpose, or manipulate your routine to push the result lower. The goal is an accurate repeat measurement, not a number that crosses a cutoff.
Your test #2 checklist
- Confirm the timing. Early morning is the standard starting point for men with conventional sleep schedules.
- Ask whether fasting is required. The Endocrine Society recommends it; the AUA does not make it universal; payer rules can be stricter.
- Keep the testing method consistent when practical. A different assay or laboratory can add another source of variation. Some coverage policies explicitly require the same laboratory.
- Tell the clinician if you are acutely ill. Illness can temporarily lower testosterone and may change when the clinician wants the test done.
- Do not stop a prescription medicine just to change the result. Ask the prescribing clinician before changing any medicine.
- Follow the lab's supplement instructions. Some testosterone panels give specific instructions for biotin or other supplements.
- Save both actual reports. A clinician or insurer may need the collection time, reference range, method and result—not just a number copied into your phone.
- If the first result was borderline, ask whether free testosterone is appropriate. The Endocrine Society recommends free testosterone when total testosterone is near the lower limit or SHBG is likely to be altered.
Don't try to “make” the second test low. We get why the thought happens. If you feel awful, a normal result can feel like losing the explanation you finally found. But the second test exists to learn whether the low level is real and repeatable. Deliberately changing sleep, food, exercise or medicine to drive the number down defeats the point and can lead the workup in the wrong direction.
Does an at-home finger-prick test count as one of the two?
It depends on the test, clinician and payer. The AUA and FDA labeling discuss serum testosterone, and many insurance criteria are written around laboratory serum measurements. A dried-blood-spot or other home method may be useful for screening or a program's own process, but it may not satisfy the confirmation standard another clinician or insurer uses.
If a home result is going to influence a diagnosis or coverage decision, ask two questions before relying on it:
- Will the clinician accept this method as one of the confirmatory measurements?
- Will the insurer accept it if prior authorization is required?
Our guide to at-home testosterone tests compares the major options.
Two samples in one kit are not automatically two separate test occasions
Some home kits ask for more than one sample during the same collection session. That is not the same thing as the AUA's requirement for measurements on separate occasions.
Labcorp OnDemand example
Labcorp OnDemand's Total Testosterone Test was $69 when rechecked in October 2026. Its current page says no special preparation is needed. Its separate Comprehensive Testosterone Test recommends collection between 7 and 10 a.m.
If you plan to use a direct-to-consumer result in a clinical workup, tell the clinician how and when it was collected. A consumer test page is not a substitute for the diagnostic instructions that apply to your situation.
What if one testosterone test is low and the other is normal?
Then your results disagree. You did not fail anything. The AUA says that if the first result is below 300 ng/dL and the second is normal, the clinician should use judgment about whether a third test should be used as a control.
This is the result that sends many people back to searching, so here are the common patterns in one place.
“My second test came back ___”
| Your two results | What it can mean | Reasonable question to ask next |
|---|---|---|
| Both clearly low, plus symptoms/signs | Fits key elements of the guideline picture | What is causing the low testosterone, and what else needs to be checked before treatment? |
| One low, one clearly normal | The measurements are discordant | Does the timing, illness, assay or clinical picture justify a third early-morning measurement? |
| One low, one borderline | The picture is still uncertain | Is free testosterone appropriate, and should the total testosterone be repeated? |
| Both normal, symptoms continue | The symptoms may have another cause | What other conditions or medicines should be evaluated? |
| Very low result with headaches, vision changes or other pituitary warning signs | A pituitary or other medical cause may need prompt evaluation | Should this be evaluated in person by primary care, endocrinology or another specialist? |
Why results disagree: time of day, acute illness, normal day-to-day variation, laboratory method, changed sleep patterns and some medicines can all affect interpretation.
Can you get TRT with one low test anyway? A prescription decision belongs to a licensed clinician acting under applicable law and clinical standards. But one isolated low result does not meet the AUA's two-test diagnostic recommendation, and current FDA testosterone labeling tells clinicians to confirm low serum testosterone on at least two separate morning days before initiating the labeled product.
Got one low and one normal result? Find My TRT Path can help you map the questions to ask next and whether primary care, urology, endocrinology, reproductive urology or an online care route makes sense. It does not diagnose you or decide whether you qualify for TRT.
Do both testosterone tests have to be below 300 ng/dL?
Not in a strict “299 means yes, 301 means no” way. The AUA calls total testosterone below 300 ng/dL a reasonable cutoff in support of diagnosis, but it also requires symptoms or signs and repeat early-morning measurements. Other guidelines, laboratories and coverage policies may use a reference range or additional free-testosterone criteria.
Three kinds of numbers show up:
- 300 ng/dL. This is the AUA's supporting cutoff. The Endocrine Society's July 2026 statement describes a common clinical threshold near 300 ng/dL.
- Your lab's reference range. Some FDA labeling and payer policies use “below the normal range” rather than one universal numeric threshold.
- Free testosterone in selected cases. The Endocrine Society recommends measuring free testosterone when total testosterone is near the lower limit of normal or when a condition alters SHBG.
Want to go deeper on the numbers? See what testosterone level qualifies for TRT, our free testosterone calculator, and our comparison of reference ranges across major labs.
Does insurance require two low testosterone tests for TRT?
Many coverage policies do, but there is no single insurer rule for the entire U.S. The policies we rechecked use different timing, cutoff, free-testosterone and documentation rules, and some plans carve out special cases. Your own plan's current prior-authorization criteria are the final coverage rule.
This is why an insurance requirement should not be treated as if it were the medical guideline itself.
Coverage policies we rechecked
| Insurer or program | Current/public criterion we verified | Morning requirement | Other notable detail |
|---|---|---|---|
| Aetna — testosterone cypionate | At least two confirmed low morning testosterone levels before treatment for primary or hypogonadotropic hypogonadism | Yes | Based on reference lab range or current practice guidelines |
| Aetna — testosterone pellets | At least two confirmed low morning levels | 7–10 a.m. in appendix criteria | Different days; fasting criteria described in appendix |
| Cigna — injectable/implantable testosterone policy | Uses the two-separate-early-morning diagnostic framework in its criteria/background | Yes | Symptoms/signs remain part of the diagnosis |
| UnitedHealthcare — commercial medical benefit | Two pretreatment early-morning total testosterone levels below 300 ng/dL or the lab range, taken at separate times, unless an allowed alternative pathway applies | Yes | Free/bioavailable testosterone pathway exists for altered SHBG |
| CVS Caremark — topical/nasal products | Current public PA form says the plan may require two morning testosterone tests before treatment | Yes | Exact approvable range is plan-specific |
| BCBS Mississippi | Two low total testosterone levels | 8–10 a.m. | Different days; below the normal laboratory range |
| Kaiser Permanente Northwest | Two low morning testosterone levels | Yes | If BMI is 30 or higher, public criteria also require low free testosterone |
| Washington Medicaid | Two morning baseline tests | 8–10 a.m. | At least 1 week and no more than 3 months apart |
| Oklahoma Medicaid | Two pre-medication morning testosterone labs below 300 ng/dL for the main hypogonadism pathway | Yes | Also requires gonadotropin information unless an exception applies |
| Medicare — Palmetto GBA L39086 | At least two separate fasting serum testosterone levels | Before 10 a.m. | Different days; identical laboratories; LH or FSH |
| Medicare — Noridian L36538 | At least two separate serum testosterone levels | Two different mornings | LH or FSH and symptoms documented |
What the pattern shows: repeat morning testing is common, but the details are not interchangeable. One payer may use the lab's range, another may use 300 ng/dL, another may allow a free-testosterone pathway, and another may require a particular gap between tests.
How to avoid a preventable coverage problem
- Get the current prior-authorization criteria for your exact plan before the second test.
- Match its collection window if it sets one.
- Ask whether the plan requires the same laboratory or specific assay documentation.
- Make sure the clinician has the symptoms/signs and relevant history documented when the policy requires them.
- Ask whether LH, FSH, free testosterone or other laboratory work is part of the coverage pathway.
Paying cash? An insurer's prior-authorization rule does not control a cash-pay clinic. The clinical diagnostic guidance still matters, and a future insurer may want its own pretreatment documentation.
If both testosterone tests are low, can you start TRT?
Not automatically. Two low results are one key piece. A clinician still needs to consider symptoms or signs, why testosterone is low, relevant safety factors and fertility plans before deciding whether testosterone treatment is appropriate.
Think of two low results as opening the clinical conversation, not writing the prescription.
Symptoms or signs have to be there too
The AUA says the clinical diagnosis of testosterone deficiency is made only when low total testosterone is combined with symptoms and/or signs. The Endocrine Society likewise says symptoms alone are not diagnostic and calls for consistently low, accurately measured testosterone.
Finding out why it is low
The Endocrine Society recommends measuring LH (luteinizing hormone) and FSH (follicle-stimulating hormone) to distinguish primary from secondary hypogonadism. Depending on those results and the clinical picture, a clinician may order additional tests such as prolactin.
If you want kids, read this before anything else
Testosterone therapy can suppress sperm production. The Endocrine Society recommends against starting testosterone therapy in men planning fertility in the near term, and the AUA/ASRM male-infertility guideline says testosterone monotherapy should not be prescribed to men interested in current or future fertility.
If near-term fertility matters to you, reproductive urology or another fertility-aware clinician is the better starting point. Other medicines sometimes used in fertility-focused care are not the same as TRT and should not be treated as interchangeable substitutes. See TRT and fertility.
Reasons an in-person or specialist evaluation may be the better starting point
An in-person or specialist evaluation may be more appropriate when there are signs of pituitary disease, very abnormal results, fertility concerns, a prostate or breast cancer history, elevated hematocrit, untreated severe sleep apnea, a recent major cardiovascular event, or another complex medical issue. The Endocrine Society specifically lists several of these conditions among situations in which testosterone therapy should not be started without the appropriate evaluation.
For a sudden severe headache with vision loss or another emergency symptom, seek emergency care.
The legal side
Testosterone is a Schedule III controlled substance in the United States and requires a valid prescription. Under the current DEA/HHS temporary rule, the COVID-era telemedicine flexibilities for prescribing controlled medications have been extended through December 31, 2026. The federal extension does not erase state law or other prescribing requirements.
No online questionnaire by itself diagnoses low testosterone or guarantees a testosterone prescription.
Do online TRT programs require two low testosterone tests?
Public policies are inconsistent. Among the programs we rechecked for this page, Hone Health clearly publishes a mandatory confirmatory test for patients moving forward with TRT. Male Excel publishes a required at-home lab step before its provider consultation but does not clearly publish a two-test rule on its current TRT process page. Taurus Meds publishes lab-first testing and consultation steps but its current patient-facing offer does not clearly state a second-test requirement.
That difference matters because a program's own intake process and a medical guideline are not the same thing.
Online programs: what they currently publish
| Program | What the public process says | Clear second-test rule? | Current testing price information |
|---|---|---|---|
| Hone Health | Initial lab testing, clinician review, then confirmatory testing if TRT is being considered/prescribed | Yes | Men's Plus help page lists a $45 initial test and $45 at-lab or $80 at-home confirmatory test; Hone Premium publishes a separate $25 at-lab confirmatory panel |
| Male Excel | $99 at-home lab test and provider consultation; current TRT page says the at-home lab test is completed before the provider consultation | Not clearly stated on the current TRT process page | $99 start; $99/month medical membership; medications priced separately |
| Taurus Meds | Lab testing followed by video consultation and a clinician treatment decision | Not clearly stated on the current patient-facing testing page | Current testing page shows $49 for the testosterone lab test and clinician review; Taurus's homepage also displays a “free testosterone test” promotion, so confirm the live offer before paying |
"Not clearly stated" means we could not verify a public second-test rule on the current process page. It does not mean the clinician will never order a repeat test.
What we actually verified
Date: October 2, 2026
Hone Health: Current help-center pages describe mandatory confirmatory testing for TRT. The Men's Plus membership page lists a $45 initial test and a confirmatory test of $45 at a lab or $80 at home. Hone Premium publishes a different $25 at-lab confirmatory panel, so the cost depends on the plan.
Male Excel: Current TRT pages show a $99 start that includes the at-home lab test and provider consultation, a $99/month medical membership, and medications priced separately. Its current TRT page says testing is completed before the provider consultation. We did not preserve the older claim that Male Excel can prescribe before lab results arrive because the current public process does not support it.
Taurus Meds: The current testing page shows a $49 lab test with clinician review, while the homepage promotes a free testosterone test. Because those public offers conflict, the final price should be confirmed on the checkout path before payment.
Not independently tested by us: We did not buy a kit, complete intake, receive care, contact support, or verify the clinical decision made for an individual patient.
Want the second test built into the published process? Hone Health is the clearest example
Hone is the clearest of these three programs on confirmatory testing. Its current help center says that if initial results suggest eligibility for TRT, a confirmatory panel is required before therapy and includes a second total testosterone measurement plus other safety markers.
That does not mean Hone is automatically the right provider for you. It means its public testing process is clearer on this specific question.
Male Excel: lab testing is published, but a two-test rule is not
Male Excel currently says its $99 start includes an at-home lab test and provider consultation, and its TRT page says the at-home lab test is completed before the consultation. Its public TRT process does not clearly state that every patient must complete a second confirmatory testosterone test before a prescribing decision.
If you are considering Male Excel after already having two separate morning lab results, bring those reports and ask how the provider will use them and whether another test is required.
Taurus Meds: ask about both the second test and the live test price
Taurus publishes a lab-first process, then a video consultation and clinician decision. Its current patient-facing testing page does not clearly state whether a second low morning testosterone test is required in every TRT case.
It also has conflicting public price language: the dedicated testing page shows $49, while the homepage advertises a free testosterone test. Ask which written offer applies before paying.
5 questions to ask any online clinic before you pay
- Will you confirm a low testosterone result with another early-morning measurement on a separate occasion when clinically appropriate?
- What laboratory method is used, and will an outside laboratory result be accepted?
- Who pays for any confirmatory or additional testing?
- If total testosterone is borderline, when do you use free testosterone, LH, FSH or prolactin?
- How do you handle fertility plans before considering testosterone treatment?
A clinic should be able to explain its process without implying that a questionnaire or one number guarantees a prescription.
Frequently asked questions
Can I get TRT with just one low testosterone test?
One low result does not meet the AUA's two-test diagnostic recommendation. Current FDA testosterone labeling also tells clinicians to confirm low serum testosterone on at least two separate morning days before initiating the labeled product. A clinician still has to consider symptoms or signs, cause, safety and the rest of the evaluation.
Do both testosterone tests have to be under 300 ng/dL?
Not as a simple pass/fail rule. The AUA calls total testosterone below 300 ng/dL a reasonable cutoff in support of diagnosis, but it also requires symptoms or signs and repeat testing. Some payer criteria use the laboratory's own reference range or allow specific free-testosterone pathways.
What time should I take my second testosterone test?
Early morning is the usual guideline-based timing for men with conventional sleep schedules. Some payer policies use specific windows such as 8–10 a.m. If you work nights or have an unusual sleep schedule, ask your clinician how they want the test timed.
Do I need to fast before a testosterone test?
The Endocrine Society recommends fasting morning testing; the AUA does not require clinicians to insist on fasting. Follow the instructions attached to your actual lab order and any payer rule that applies.
How far apart should my two testosterone tests be?
The AUA does not set one evidence-based number of days. It calls for separate occasions. Some payer policies add their own timing rule, such as Washington Medicaid's 1-week-to-3-month window.
What if my second testosterone test came back normal?
Then the results are discordant, and that is useful information. The AUA says clinician judgment can be used to decide whether a third test should serve as a control when the first result is below 300 ng/dL and the second is normal.
Can an at-home test count as one of my two tests?
Possibly, but do not assume it will. The clinician has to accept the method for diagnosis, and an insurer may have its own serum-testing or laboratory documentation rule. Ask before relying on a home result as one of the confirmatory measurements.
Will insurance cover my second testosterone test?
Coverage depends on the plan and the reason for testing. Some plans require repeat testing for authorization, but coverage of the laboratory charge itself varies. Check the plan's benefits and prior-authorization criteria before assuming the test is covered.
Do I need free testosterone tested too?
Sometimes. The Endocrine Society recommends free testosterone when total testosterone is near the lower limit of normal or when a condition alters SHBG. It is not a universal replacement for the two-test total-testosterone framework.
What happens after two low testosterone tests?
A clinician still has to connect the laboratory results to symptoms or signs, determine the likely cause, review relevant safety issues and discuss fertility. Two low numbers do not automatically mean TRT is appropriate or that a prescription will be issued.
How we built this page
We rechecked the AUA testosterone deficiency guideline, the Endocrine Society's 2018 guideline and July 2026 statement, current FDA testosterone labeling, the DEA/HHS telemedicine extension, selected current or publicly available payer policies, and current public testing pages from Hone Health, Male Excel and Taurus Meds. Everything was rechecked for this version on October 2, 2026.
We keep verified facts, provider statements and editorial conclusions separate, following How We Review TRT Providers. Provider prices, payer rules and telemedicine requirements can change, so any volatile fact on this page carries a verification date.
Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.
Educational information only, not medical advice. TRT Provider Guide is not a clinic, pharmacy, laboratory, insurer or medical practice.
Sources
- American Urological Association. Evaluation and Management of Testosterone Deficiency guideline and full text PDF.
- Endocrine Society. Testosterone Therapy in Men With Hypogonadism clinical practice guideline (2018).
- Endocrine Society. Statement on Testosterone Replacement Therapy (July 16, 2026).
- U.S. Food and Drug Administration. Testim prescribing information (2025 label).
- Centers for Medicare & Medicaid Services. LCD L39086, Palmetto GBA; LCD L36538, Noridian.
- CDC. Hormone Standardization (HoSt) program.
- DEA/HHS. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications (effective through December 31, 2026).
- DEA Diversion Control Division. Controlled Substance Schedules.
- AUA/ASRM. Diagnosis and Treatment of Infertility in Men guideline.
- Aetna. Testosterone Cypionate Injections policy and Implantable Hormone Pellets policy.
- CVS Caremark. Testosterone Topical/Nasal Prior Authorization.
- UnitedHealthcare. Testosterone Replacement or Supplementation Therapy — Commercial.
- Blue Cross & Blue Shield of Mississippi. Testosterone Replacement Therapy policy.
- Kaiser Permanente Northwest. Testosterone Cypionate coverage criteria.
- Washington State Health Care Authority. Testosterone Replacement Therapy policy.
- Oklahoma Health Care Authority. Testosterone prior-authorization criteria.
- Labcorp OnDemand. Total Testosterone Test and Comprehensive Testosterone Test.
- Hone Health Help Center. Men's Plus membership, TRT lab testing schedule, and sample timing.
- Male Excel. TRT Online, At-Home Hormone Test, and Terms & Conditions.
- Taurus Meds. Testosterone blood-test page and homepage.